To learn more about the study below, or other studies, please call us at 1-866-444-1132. Vulvar High-Grade Squamous Intraepithelial Lesion (HSIL) Researchers with the National Cancer Institute in Bethesda, Maryland are recruiting women with Vulvar High-Grade Squamous Intraepithelial Lesion (HSIL) for a first-of-its-kind treatment study. This study is being done to determine if a personalized immuneContinue reading “Personalized immune treatment to rid the body of the HPV virus that causes HSIL”